🔎 Trials Near Me

Home › Adenocarcinoma esofageo › New York

Studi clinici su Adenocarcinoma esofageo nello stato di New York

20 studi su Adenocarcinoma esofageo cercano partecipanti presso sedi nello stato di New York.

Città nello stato di New York

Testo ufficiale dello studio (inglese)

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

  • Northwell Health Imbert Cancer Center, Bay Shore
  • Roswell Park Cancer Institute, Buffalo
  • Northwell Health Cancer Institute at Huntington, Greenlawn
  • e altri 7
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

  • New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
  • The New York Hospital Medical Center of Queens, Flushing
  • Glens Falls Hospital, Glens Falls
  • e altri 13
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05677490

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

  • Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
  • Memorial Sloan Kettering Cancer Center, New York
  • Local Institution - 0274, Rochester
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07221149

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • Memorial Sloan-Kettering Cancer Center, New York
  • New York Cancer & Blood Specialists, Shirley
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06324357

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

  • Memorial Sloan Kettering Cancer Center Pharmacy (IMP ship to address), Long Island City
  • Memorial Sloan Kettering Cancer Center Pharmacy (IMP storage location), Long Island City
  • Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
  • e altri 2
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07392892

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • Columbia University Irving Medical Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07277413

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas

  • New York Oncology Hematology, Albany
  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07546812

A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma

  • Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
  • e altri 1
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07818018

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

  • Long Island Jewish Medical Center, Manhasset
  • Columbia Universtiy, New York
  • University of Rochester Medical Center, Rochester
In reclutamento
Età da 18 a 89 · Tutti i sessi · Aggiornato il 11 set 2026 · NCT05753748

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

  • Research Site, New York
  • Research Site, New York
  • Research Site, New York
  • e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07431281

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • NYU Langone Health, New York
  • Icahn School of Medicine At Mount Sinai Prime, New York
  • Clinical Research Alliance, Inc, Westbury
  • e altri 1
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ago 2026 · NCT06330064

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

  • START New York, Lake Success
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
  • Icahn School of Medicine at Mount Sinai, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 lug 2026 · NCT06657144

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
  • e altri 7
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT04389632

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

  • Long Island Jewish Medical Center, New Hyde Park
  • Weill Cornell Medicine, New York
  • University of Rochester, Rochester
In reclutamento
Età da 18 a 89 · Tutti i sessi · Aggiornato il 1 lug 2026 · NCT05530343

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

  • Research Site, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 giu 2026 · NCT07284186

Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

  • Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 apr 2026 · NCT06340711

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

  • NYU Langone, New York
  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 mar 2026 · NCT04900818

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 feb 2026 · NCT06623396

Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • Roswell Park Cancer Institute, Buffalo
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 gen 2026 · NCT04682158

Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma

  • Roswell Park Cancer Institute, Buffalo
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 dic 2025 · NCT05651594

Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.